Support the Wall Street Examiner! Choose your level of support to receive a free proprietary report as my thanks. Click the button below to see your options. Become a Patron!

March 22 COVID2019 in Numbers

This is a syndicated repost courtesy of True Economics. To view original, click here. Reposted with permission.

Updating numbers for Corona Virus infections and related deaths:

Liquidity moves markets!

Follow the money. Find the profits! 

Next up, comparing Italy and U.S. numbers in terms of their dynamics from the start of the infection detections in each country (date 30) to today:

Note, while the U.S. infections dynamics have overtaken Italy already, U.S. death rates remain well below those in Italy. This is due to a range of factors, none of which are particularly satisfactory for the U.S. healthcare system assessment:

  1. Italian demographics and deaths cases suggest that Italian patients were more likely to die from the disease earlier on after the detection than the U.S. patients.
  2. Higher population density and concentration of the virus cases in Italy mean greater strain on healthcare resources in specific locations in Italy than in the U.S.
  3. rates of detection and treatment are most likely much higher in Italy than in the U.S. due to more severe restrictions in the U.S. in accessing healthcare.
I covered some of these earlier here: https://trueeconomics.blogspot.com/2020/03/15320-acute-beds-and-hospital-beds.html. But here is an added kicker not mentioned in the linked post: the U.S. is now facing a massive wave of ongoing layoffs. As workers lose their jobs, they also lose access to health insurance (the continuity coverage program, COBRA, is excruciatingly expensive).

Wall Street Examiner Disclosure:Lee Adler, The Wall Street Examiner reposts third party content with the permission of the publisher. I curate posts here on the basis of whether they represent an interesting and logical point of view, that may or may not agree with my own views. Some of the content includes the original publisher's promotional messages. I may receive promotional consideration on a contingent basis, when paid subscriptions result. The opinions expressed in these reposts are not those of the Wall Street Examiner or Lee Adler, unless authored by me, under my byline. No endorsement of third party content is either expressed or implied by posting the content. Do your own due diligence when considering the offerings of information providers.

Try Lee Adler's Technical Trader risk free for 90 days! Follow the money. Find the profits!

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.